S.No | Ailment | Route | Dose Min | Dose Max | Unit | Dosage Form | Frequency | Additional Info |
---|---|---|---|---|---|---|---|---|
1 | Acute severe disease | Oral | 4 | 48 | mg | Tablet | Daily, but higher initial doses of up to 100 mg or more daily. | |
2 | Acute severe disease | i.v/i.m | 10 | 500 | mg | Injection | Daily. | |
3 | Intensive therapy of acute spinal cord injury | IV bolus | 30 | mg/kg | Injection | Over 15 minutes and followed, after a 45-minute pause, by intravenous infusion of 5.4 mg/kg per hour over 24 hours or longer. | ||
4 | For a prolonged systemic effect | IM | 40 | mg | Injection | Every 2 weeks to 120 mg weekly. | ||
5 | For injection into soft tissues | intra-articular injection | 4 | 80 | mg | Injection | According to the size of the affected joint. |
S.No | Ailment | Age Min | Age Max | Weight ( Kg ) | Route | Dose Min | Dose Max | Unit | Dosage Form | Frequency | Additional Info |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | Inflammatory and allergic disorders | 1 Month | 18 Year | Oral | 0.5 | 1.7 | mg/kg | Tablet | |||
2 | Inflammatory and allergic disorders | IV | 10 | 30 | mg/kg | Injection | o.d. | ||||
3 | Graft rejection | IV | 10 | 20 | mg/kg | Injection | o.d. |
Pathway of DIETARY Product
DIETARY Substance Interactions
ContraIndication DIETARY Substance